Malignant Genitourinary System Neoplasm: Clinical Trials

5 trials for Malignant Genitourinary System Neoplasm, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 active not recruiting, 2 recruiting, 1 completed. 5 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 15Active not recruiting 2, Recruiting 2, Completed 1
Phase 21Active not recruiting 1

Follow Malignant Genitourinary System Neoplasm: new trials by email Literature Review of Malignant Genitourinary System Neoplasm trials Research Report on Malignant Genitourinary System Neoplasm

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer
Best Practice, Biospecimen Collection, Endoscopic Procedure - Clinical Stage 0 Cutaneous Melanoma AJCC v8, Clinical Stage I Cutaneous Melanoma AJCC v8
Phase 1RecruitingM.D. Anderson Cancer Center8002021-02-212026-07-15
Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
Fecal Microbiota Transplantation, Loperamide - Colitis, Diarrhea
Phase 1RecruitingM.D. Anderson Cancer Center402021-02-012026-09-18
Infliximab or Vedolizumab in Treating Immune Checkpoint Inhibitor-Related Colitis in Patients With Genitourinary Cancer or Melanoma
Infliximab, Vedolizumab - Colitis, Lung Non-Small Cell Carcinoma
Phase 1 / Phase 2Active not recruitingM.D. Anderson Cancer Center472020-07-092026-07-15
Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study
Biospecimen Collection, Genetic Counseling, Genetic Testing - Breast Carcinoma, Digestive System Neoplasm
Phase 1CompletedMayo Clinic2302020-06-292023-07-24
Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors
Biopsy Procedure, Biospecimen Collection, Cabozantinib S-malate - Bladder Small Cell Neuroendocrine Carcinoma, Bladder Squamous Cell Carcinoma
Phase 1Active not recruitingNational Cancer Institute (NCI)1522015-07-222026-11-12

Narrower conditions

Urogenital Neoplasms (5)  ·  Colitis (3)  ·  Breast Neoplasms (2)  ·  Carcinoma, Non-Small-Cell Lung (2)  ·  Lung Neoplasms (2)  ·  Melanoma (2)  ·  Brain Neoplasms (1)  ·  Carcinoma, Renal Cell (1)  ·  Central Nervous System Neoplasms (1)  ·  Diarrhea (1)  ·  Digestive System Neoplasms (1)  ·  Head and Neck Neoplasms (1)  ·  Neoplasms, Unknown Primary (1)  ·  Ovarian Neoplasms (1)  ·  Penile Neoplasms (1)

Broader conditions

Female Urogenital Diseases (5)  ·  Female Urogenital Diseases and Pregnancy Complications (5)  ·  Male Urogenital Diseases (5)  ·  Neoplasms (5)  ·  Neoplasms by Site (5)  ·  Urogenital Diseases (5)  ·  Digestive System Diseases (4)  ·  Colonic Diseases (3)  ·  Gastroenteritis (3)  ·  Gastrointestinal Diseases (3)  ·  Intestinal Diseases (3)  ·  Lung Diseases (3)  ·  Neoplasms by Histologic Type (3)  ·  Respiratory Tract Diseases (3)  ·  Respiratory Tract Neoplasms (3)

Interventions

CT-P13 (2)  ·  Disulfides (2)  ·  Fecal Microbiota Transplantation (2)  ·  Immunoglobulin G (2)  ·  Infliximab (2)  ·  LDP-02 (2)  ·  vedolizumab (2)  ·  Biopsy (1)  ·  CTLA-4 Antigen (1)  ·  Endoscopy (1)  ·  Genetic Counseling (1)  ·  Genetic Testing (1)  ·  Ipilimumab (1)  ·  Loperamide (1)  ·  Magnetic Resonance Spectroscopy (1)

Sponsors

M.D. Anderson Cancer Center (3)  ·  Mayo Clinic (1)  ·  National Cancer Institute (NCI) (1)

Countries

United States (5)

Top investigators

Yinghong Wang (3)  ·  Andrea B Apolo (1)  ·  Niloy J Samadder (1)

Results publications

PMID 32915679, PMID 35031545, PMID 38954785, PMID 42735684

NIH funding

UM1CA186712 (1), UM1CA186716 (1), UM1CA186717 (1), ZIABC011078 (1)